Patents by Inventor Abdelmajid Belouchi

Abdelmajid Belouchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100291551
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to IBD (e.g. Crohn's Disease) and/or their response to a particular drug or drugs.
    Type: Application
    Filed: November 16, 2007
    Publication date: November 18, 2010
    Applicant: GENIZON BIOSCIENCES INC.
    Inventor: Abdelmajid Belouchi
  • Publication number: 20100144538
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to SCHIZOPHRENIA disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: March 10, 2008
    Publication date: June 10, 2010
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Helene Fournier, Pascal Croteau, Nouzha Paquin, Daniel Dubois, Vanessa Bruat, Paul Van Eerdewegh, Jonathan Segal, Randall David Little, Tim Keith
  • Publication number: 20100120627
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to psoriasis disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: August 2, 2006
    Publication date: May 13, 2010
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquian, Quynh Nguyen-Huu, Pascal Croteau, Rene Allard, Randall David Little, Johanne Cousineau, Sophie Debrus, Tim Keith, Natali Henderson, Daniel Dubois, Paul Van Eerdewegh, Jonathan Segal
  • Publication number: 20100120628
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to ADHD disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: February 6, 2008
    Publication date: May 13, 2010
    Applicant: GENIZON BIOSCIENCES INC.
    Inventors: Abdelmajid Belouchi, Vanessa Bruat, Pascal Croteau, Daniel Dubois, Randall David Little, Bruno Paquin, John Verner Raelson, Jonathan Segal, Paul Van Eerdewegh, Sandie Briand, Sem Kebache, Tim Keith
  • Publication number: 20100099083
    Abstract: The present invention relates to the ATG16l1 gene and genetic variants associated with Crohn's disease. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: July 26, 2007
    Publication date: April 22, 2010
    Applicant: GENIZON BIOSCIENCES INC
    Inventors: John Verner Raelson, Stefan Schreiber, Randall David Little, Andre Franke, Jochen Hampe, Tim Keith, Vanessa Bruat, Abdelmajid Belouchi
  • Publication number: 20100081129
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: May 1, 2006
    Publication date: April 1, 2010
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Hélene Fournier, Quynh Nguyen-Huu, Pascal Croteau, Réne Allard, Sophie Debrus, Valerie Serre, Paul Van Eerdewegh, Randall David Little, Jonathan Segal, Tim Keith
  • Publication number: 20100028873
    Abstract: The present invention provides a nucleic acid sequencing method. The method comprises enriching a nucleic acid sample for target nucleic acids, where the nucleic acid sample is enriched through at least a first round of hybridization selection and amplification, and a second round of hybridization selection and amplification. The enriched nucleic acids are in a form convenient for sequencing with the Cantaloupe sequencing technology, which employs shotgun sequencing by hybridization (SBH) of immobilized rolling circle amplicons.
    Type: Application
    Filed: March 14, 2007
    Publication date: February 4, 2010
    Inventors: Abdelmajid Belouchi, Steve Geoffroy, Sten Linnarsson, Pierre Berube
  • Publication number: 20090305900
    Abstract: The present invention relates to the selection of a set of SNP markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's longevity, their protection against age-related diseases and/or their response to a particular drug or drugs.
    Type: Application
    Filed: June 19, 2006
    Publication date: December 10, 2009
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Quynh Nguyen-Huu, Pascal Croteau, Rene Allard, Johanne Cousineau, Nouzha Paquin, Paul Van Eerdewegh, Randall David Little, Tim Keith, Jonathan Segal
  • Publication number: 20090181380
    Abstract: The present invention relates to the selection of a set of polymorphism makers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to IBD (ex: Chrohn's disease) and/or their response to a particular drug or drugs.
    Type: Application
    Filed: December 19, 2006
    Publication date: July 16, 2009
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Helene Fournier, Quynh Nguyen-Huu, Pascal Croteau, Rene Allard, Sandie Briand, Paul Van Eerdewegh, Randall David Little, Jonathan Segal, Tim Keith
  • Publication number: 20090081658
    Abstract: The present invention relates to the selection of a set of polymorphism markers for use in genome wide association studies based on linkage disequilibrium mapping. In particular, the invention relates to the fields of pharmacogenomics, diagnostics, patient therapy and the use of genetic haplotype information to predict an individual's susceptibility to Crohn's disease and/or their response to a particular drug or drugs.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 26, 2009
    Inventors: Abdelmajid Belouchi, John Verner Raelson, Walter Edward Bradley, Bruno Paquin, Helene Fournier, Quynh Nguyen-Huu, Pascal Croteau, Rene Allard, Sophie Debrus, Valerie Serre, Paul Van Eerdewegh, Randall David Little, Tim Keith, Jonathan Segal, Tim Keith
  • Publication number: 20050064419
    Abstract: The present invention relates to a method for enotyping microsatellite DNA markers. The described protocol is to convert a double-strand PCR fragment encoding the microsatellite of interest into a single-stranded DNA fragment of approximately 30-50 nucleotides. The produced fragment comprises the repeated region with a few flanking nucleotides and is suitable for analysis by mass spectrometry.
    Type: Application
    Filed: October 7, 2002
    Publication date: March 24, 2005
    Inventors: Abdelmajid Belouchi, Diane Saint-Louis, Bruno Paquin
  • Patent number: 6479244
    Abstract: The present invention provides a high throughput method for genotyping microsatellite markers. The technology uses a combination of oligonucleotides in a selective ligation reaction that discriminates mono-, di-, tri-, tetra-, penta-, hexa-, hepta-, octa- and nona-nucleotide repeated alleles in amplified DNA from individuals.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: November 12, 2002
    Assignee: Galileo Genomics
    Inventors: Abdelmajid Belouchi, Bruno Paquin
  • Publication number: 20020155449
    Abstract: The present invention provides a high throughput method for genotyping microsatellite markers. The technology uses a combination of oligonucleotides in a selective ligation reaction that discriminates mono-, di-, tri-, tetra-, penta-, hexa-, hepta-, octa- and nona-nucleotide repeated alleles in amplified DNA from individuals.
    Type: Application
    Filed: April 23, 2001
    Publication date: October 24, 2002
    Inventors: Abdelmajid Belouchi, Bruno Paquin
  • Patent number: 5227289
    Abstract: An assay is disclosed for identifying mutagenic agents which include large, multilocus deletion events in cultured mammalian cells. The cell lines used are adenine phosphoribosyltransferase heterozygotes derived from CHO cells, which we disclose possess a genomic sequence variation near the above-mentioned gene. We present the nucleotide sequence surrounding this variation, enabling an efficient determination of the proportion of deletion mutants among the mutant colonies induced by the agent to be tested.
    Type: Grant
    Filed: May 17, 1990
    Date of Patent: July 13, 1993
    Inventors: W. Edward C. Bradley, Abdelmajid Belouchi, Pascale Dewyse